Cargando…
Tetramethylpyrazine inhibits prostate cancer progression by downregulation of forkhead box M1
Tetramethylpyrazine (TMP) has exhibited various anticancer effects. However, its ability to inhibit proliferation, migration, and invasion of prostate cancer (PCa) PC-3 cells is still unclear. In the present study, different concentrations of TMP were co-incubated with PC-3 cells. The pcDNA-FOXM1 pl...
Autores principales: | Zhou, Yi, Ji, Zhigang, Yan, Weigang, Zhou, Zhien, Li, Hanzhong, Xiao, Yu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5561788/ https://www.ncbi.nlm.nih.gov/pubmed/28677763 http://dx.doi.org/10.3892/or.2017.5768 |
Ejemplares similares
-
The biological functions and mechanism of miR-212 in prostate cancer proliferation, migration and invasion via targeting Engrailed-2
por: Zhou, Yi, et al.
Publicado: (2017) -
Development and internal validation of a prediction model of prostate cancer on initial transperineal template-guided prostate biopsy
por: Chen, Yuliang, et al.
Publicado: (2021) -
The transverse and vertical distribution of prostate cancer in biopsy and radical prostatectomy specimens
por: Mai, Zhipeng, et al.
Publicado: (2018) -
Tumor characteristics, treatments, and survival outcomes in prostate cancer patients with a PSA level < 4 ng/ml: a population-based study
por: Zheng, Zhibo, et al.
Publicado: (2020) -
Long-term outcome of early stage prostate cancer treated with brachytherapy analysis after a mean follow-up of 7 years
por: Yan, Weigang, et al.
Publicado: (2014)